Optical theranostics and treatment dosimetry for COVID-19 lung complications: Towards increasing the survival rate of vulnerable populations

Abstract

1. •

   The progression of the COVID-19 pandemic was slowed by implemented social isolation measures and adaptation of the healthcare system.

2. •

   Still, no effective treatments for severe lung complications are available for the most susceptible populations.

3. •

   Optical theranostics methods can identify COVID-19 pulmonary manifestations and provide automated and real-time control of the treatment dosimetry.

4. •

   Optical methods are flexible for combination with existing medical devices and drug repurposing protocols.

5. •

   Implementation of reliable and safe theranostics methods requires strong collaboration among researchers, industry and medical institutions.